The present invention relates to a composition comprising nanoparticles that comprise rapamycin or a derivative thereof and a carrier protein, for use in a method of treating pulmonary hypertension in an individual. Said method may further comprise administering a composition comprising nanoparticles that comprise a taxane or a derivative thereof and a carrier protein. The present invention also relates to unit dosage forms of the compositions for use of the invention.
